BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10222574)

  • 1. Biological monitoring: the role of toxicokinetics and physiologically based pharmacokinetic modeling.
    Mason H; Wilson K
    Am Ind Hyg Assoc J; 1999; 60(2):237-42. PubMed ID: 10222574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological monitoring of tetrahydrofuran: contribution of a physiologically based pharmacokinetic model.
    Droz PO; Berode M; Jang JY
    Am Ind Hyg Assoc J; 1999; 60(2):243-8. PubMed ID: 10222575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure assessment at the workplace: implications of biological variability.
    Manini P; De Palma G; Mutti A
    Toxicol Lett; 2007 Feb; 168(3):210-8. PubMed ID: 17157456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New PBPK model applied to old occupational exposure to benzene.
    Sherwood RJ; Sinclair GC
    Am Ind Hyg Assoc J; 1999; 60(2):259-65. PubMed ID: 10222577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomonitoring for occupational health risk assessment (BOHRA).
    Manno M; Viau C; ; Cocker J; Colosio C; Lowry L; Mutti A; Nordberg M; Wang S
    Toxicol Lett; 2010 Jan; 192(1):3-16. PubMed ID: 19446015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of physiologically based pharmacokinetic models to establish biological exposure indexes.
    Leung HW
    Am Ind Hyg Assoc J; 1992 Jun; 53(6):369-74. PubMed ID: 1605109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occupational poisoning and biological exposure monitoring].
    Miyakoshi Y; Shimizu H
    Rinsho Byori; 2008 Nov; Suppl 141():19-26. PubMed ID: 20815146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological monitoring of chemical exposure].
    Jakubowski M
    Med Pr; 2004; 55(1):13-8. PubMed ID: 15156762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation.
    Thomas RS; Bigelow PL; Keefe TJ; Yang RS
    Am Ind Hyg Assoc J; 1996 Jan; 57(1):23-32. PubMed ID: 8588550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Before the storm: informing and involving stakeholder groups in workplace biomarker monitoring.
    Musham C; Trettin L; Jablonski R
    J Public Health Policy; 1999; 20(3):319-34. PubMed ID: 10874405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using compartmentalized inhalation physiologically-based pharmacokinetic modeling to calculate occupational and environmental risks: a case study involving toluene.
    Giardino NJ; Wilkes CR; Ricci PF; Wireman JR
    Appl Occup Environ Hyg; 2000 Jun; 15(6):457-62. PubMed ID: 10853284
    [No Abstract]   [Full Text] [Related]  

  • 13. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.
    Zhao P; Zhang L; Grillo JA; Liu Q; Bullock JM; Moon YJ; Song P; Brar SS; Madabushi R; Wu TC; Booth BP; Rahman NA; Reynolds KS; Gil Berglund E; Lesko LJ; Huang SM
    Clin Pharmacol Ther; 2011 Feb; 89(2):259-67. PubMed ID: 21191381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological limits of exposure: evolution of interpretative and methodologic criteria].
    Colombi A; Buratti M; Zocchetti C; Imbriani M; Ghittori S
    Med Lav; 1989; 80(1):25-42. PubMed ID: 2755383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactational transfer of volatile chemicals in breast milk.
    Fisher J; Mahle D; Bankston L; Greene R; Gearhart J
    Am Ind Hyg Assoc J; 1997 Jun; 58(6):425-31. PubMed ID: 9183837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in sources of exposure variability among groups of workers exposed to inorganic mercury.
    Symanski E; SÀllsten G; Chan W; BarregÄrd L
    Ann Occup Hyg; 2001 Nov; 45(8):677-87. PubMed ID: 11718663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.
    Sohn MD; McKone TE; Blancato JN
    J Expo Anal Environ Epidemiol; 2004 May; 14(3):204-13. PubMed ID: 15141149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological exposure indicators: quantification of biological variability using toxicokinetic modeling.
    Truchon G; Tardif R; Droz PO; Charest-Tardif G; Pierrehumbert G
    J Occup Environ Hyg; 2006 Mar; 3(3):137-43. PubMed ID: 16464817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological monitoring of occupational exposure to airborne pollutants].
    Imbriani M; Ghittori S; Colombi A; Buratti M
    Med Lav; 1989; 80(1):43-51. PubMed ID: 2755384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.